Biomedical subjects

S Butts

Publications and source records attributed to S Butts.

7 recordsLinked to original sources

PubMed2000

Rheumatology telephone helplines: an activity analysis. South and West of England Rheumatology Consortium.

BACKGROUND: Anecdotal evidence suggests that the services offered by rheumatology telephone helplines in the UK vary widely between NHS Trusts because of the lack of national or European guidelines. OBJECTIVE: To conduct an activity analysis of six NHS Trust rheumatology telephone helplines in the south and west of England. METHODS: Serial data were collected on the first 100 calls received on or after 1 January 1999 by six rheumatology helplines in the south and west of England. Background information was gathered on the management, availability, setting and purpose of each helpline. Data on the time taken to manage these calls and patient satisfaction were not collected. RESULTS: Patients with rheumatoid arthritis were the major users and no significant differences were found in the outcome of their calls between centres, but wide variations were revealed in the management of the helplines, the populations they serve and the services they offer. CONCLUSION: The rheumatology helpline services in six NHS Trusts in the south and west of England were shown to be the same in name only. They lacked uniformity in the delivery of care and accessibility to relevant patient groups. The geographical variation in service delivery may result in patient dissatisfaction and confusion if a number of hospitals are attended over the course of a patient's chronic disease. Further research is required to identify the helpline needs of the broader rheumatology population, patient satisfaction, outcomes and system costs, and to progress towards the development of national and European guidelines.

Aged↗

PubMed1999

Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.

There are three classes of RNA polymerase enzyme (RNAPs I, II and III). In systemic sclerosis (SSc), three main groups of anti-RNAP sera have been characterized by radioimmunoprecipitation techniques: anti-RNAP I/III sera, anti-RNAP I/II/III sera, and a group precipitating both RNAP II and topoisomerase I (topo I). Some sera in this third group precipitate the phosphorylated (IIO) form of RNAP II in the absence of the unphosphorylated (IIA) form. Certain other antinuclear antibodies (ANA) have also been detected in anti-RNAP IIO/IIA/topo I and anti-RNAP IIO/topo I sera. In the present study of 155 SSc patients, clinical features of individuals from each of these antibody groups were assessed and compared with those of patients from other autoantibody-defined groups. The anti-RNAP I/II/III antibody specificity was closely associated with the presence of diffuse cutaneous SSc (dc-SSc) (77.8%; cf. remaining group, 12.4%; P < 0.001; relative risk (RR) 6.3). Patients with anti-RNAP I/III antibodies also had an increased incidence of dc-SSc, but this was not significant (42.9%; cf. remainder, 15.7%). Anti-RNAP+ patients had a significantly increased incidence of renal involvement (29.0%, cf. remainder, 11.3%; P < 0.05; RR 2.6), with 40% of anti-RNAP I/II/III patients having renal disease. Meanwhile, the presence of anti-centromere antibodies (ACA) was associated with limited cutaneous SSc (lc-SSc) (100.0%; cf. remainder, 75.3%; P < 0. 005), together with reduced incidences of both renal disease (2.4%, cf. remainder, 22.1%: P < 0.01) and pulmonary fibrosis (21.4%, cf. remainder, 52.3%; P < 0.005; RR 1.9). Anti-topo I antibodies were associated with the presence of pulmonary fibrosis (69.7%; cf. remainder, 32.6%; P < 0.001; RR 2.1). A majority of anti-topo I sera were from lc-SSc patients, regardless of whether anti-topo I antibodies occurred alone (75.0%) or together with anti-RNAP IIO + IIA antibodies (75.0%), and this was similar to the remainder (86. 5%; NS). However, when anti-topo I+ patients were compared with the ACA group, and then with all anti-RNAP I+ patients (37.5% lc-SSc), significant differences were found in the occurrence of dc- versus lc-SSc (P < 0.005 and P < 0.05, respectively). In conclusion, these results confirm that there are three main groups of SSc sera, each characterized by the presence of a mutually exclusive SSc-specific autoantibody (ACA, anti-topo I or anti-RNAP I), and distinguished by patterns of cutaneous involvement and specific clinical features. It appears that, in each of the three groups of SSc patients, distinct pathological processes are occurring, which are responsible for the characteristic symptoms, for the modification of particular autoantigens and, consequently, for the production of particular autoantibodies. Based on these data, together with our previous results, it is further hypothesized that anti-RNAP II antibodies may be produced in the context of two different immune response pathways.

Antibodies, Antinuclear↗

PubMed1999

Cochlear reimplantation.

OBJECTIVE: A small number of multichannel cochlear implant (CI) recipients require reimplantation. This study describes the causes of failure, surgical technique, and hearing outcomes in a consecutive series of 16 patients undergoing reimplantation of multichannel devices. We hypothesize that reimplantation is safe and that hearing results are at least as good as those measured following primary implantation. STUDY DESIGN: Retrospective analysis of consecutive clinical series. METHODS: Chart analysis of 191 consecutive CI operations performed at the University of Miami Ear Institute between 1990 and 1997 revealed 16 patients who received a second multichannel device. All but one had a minimum follow-up of 1 year after reimplantation. Ten of these patients had initial implantation performed by us, and six were initially operated on elsewhere. Main outcomes of the initial procedure were compared with those of the reimplantation, including electrode insertion length, number of channels programmed, and audiometric results. In addition, cause of failure and relevant surgical findings at the second procedure are described. RESULTS: There were no surgical complications after reimplantation surgery. Device failure was the most frequent cause for reimplantation. Time between initial implantation and failure ranged from 0 to 46 months (mean, 22.4 mo; median, 23 mo). Common intraoperative findings include mastoid fibrosis, bone growth at the cochleostomy, and skin flap breakdown. Following reimplantation, mean length of insertion, number of channels actively programmed, and speech recognition scores were at least as good as findings before initial implant failure. CONCLUSION: CI reimplantation is safe and effective.

Adolescent↗

PubMed1999

Using the CLARION cochlear implant in cochlear ossification.

This paper is a retrospective review of 5 patients with various degrees of cochlear ossification who were implanted with the CLARION Multi-Strategy Cochlear Implant. Preoperative computed tomography scans, intraoperative findings, surgical technique, and hearing outcomes are discussed in a case report format. Full implantation was achieved in all cases by a systematic approach that included drill-through of proximal obstruction (2 cases), scala vestibuli insertion (2 cases), and complete drill-out (1 case). The only complication was delayed wound healing in a patient with sickle cell disease, chronic active hepatitis, and steroid dependency on antimetabolite therapy. Early results show that the 4 patients with at least 3 months of experience have a mean open-set sentence recognition score of 55% and a mean open-set word recognition score of 24%. The conclusion is that implantation of the Clarion device in ossified cochleas can be successful in all degrees of ossification and can provide significant hearing benefit.

Adolescent↗

PubMed1999

Using electrically evoked auditory reflex thresholds to fit the CLARION cochlear implant.

This paper describes a method for measuring electrically elicited auditory reflex thresholds (EARTs) in young children who use the CLARION Multi-Strategy Cochlear Implant. The EART is an objective measure that can guide the fitting of a cochlear implant in individuals who are unable to perform behavioral tasks required to program the device. Reflexes were obtained in 11 of 17 pediatric Clarion users. The EART current level indicated a point at which an auditory percept was present and the sound was loud, but not uncomfortable. The EART then was used as a basis for conditioning behavioral responses, and as a guideline for setting most comfortable loudness levels.

Cochlear Implantation↗

PubMed1999

Speech recognition after implantation of the ossified cochlea.

OBJECTIVE: Insertion of complex, multichannel cochlear implant (CI) electrode arrays into ossified cochleas is now performed routinely. This study describes the hearing results obtained in a consecutive series of 21 patients with obstructed cochleas and compares these results to those in patients with open cochleas. The purpose of this study was to determine whether patients with ossification have speech perception results that are inferior to those of patients with no evidence of cochlear bone formation. STUDY DESIGN: Retrospective analysis of consecutive clinical series. METHODS: CI database review of 191 CI procedures at the University of Miami Ear Institute between 1990 and 1997 showed that 24 (13%) procedures were performed on patients with ossified cochleas. Open-set speech recognition scores obtained on the 11 pediatric and 7 adult English-speaking patients are compared to scores of 51 adult and 61 pediatric English-speaking CI patients with open scala. RESULTS: Results of open-set speech recognition measures in adults and children with ossified cochleas were not significantly different from those of the reference groups. CONCLUSION: Speech recognition results of patients with ossified cochleas are essentially equal to those of patients with open cochleas. Degree of obstruction appears to have less effect on outcome than other factors such as duration of profound deafness or communication methodology in children among this group.

Adolescent↗

PubMed1999

Hearing results with deep insertion of cochlear implant electrodes.

OBJECTIVE: This study aimed to investigate the relationship of electrode insertion length and speech recognition in patients using Nucleus-22 cochlear implants. STUDY DESIGN: The study design was a retrospective review of a consecutive clinical series. SETTING: The study was conducted at an academic medical center. PATIENTS: Thirty-one postlingually deafened adults with at least 6 months' experience with a Nucleus-22 cochlear implant using Spectra-22 processor and SPEAK strategy participated. MAIN OUTCOME MEASURES: Open-set speech recognition scores for words and sentences were measured. RESULTS: Insertion length ranged from 22 rings (estimated 17 mm) to 32 rings (estimated 25 mm). Mean word recognition score was 35%. Mean sentence score was 69.6%. Statistical analysis showed no correlation between insertion depth and word or sentence scores. CONCLUSION: Insertion of the Nucleus-22 array beyond 22 rings does not improve performance in speech recognition. This finding cannot be generalized to other electrodes or processing strategies.

Adult↗